Skip to content

Young people

Print as a PDF

Overview

  • Rates of chlamydia and gonorrhoea diagnoses in Australia are highest among people aged 15-29 years.
  • Most young people attend a general practice at least once a year, and are often unaware of their risk of infection and that sexually transmitted infections (STIs) are often asymptomatic. The 9th edition of the RACGP Guidelines for Preventive Activities in General Practice recommends opportunistic testing for chlamydia infection in all sexually active people aged 15-29 years. Currently, chlamydia is detected in approximately 1 in 20 young Australians who have screening tests in general practice.
  • Negotiating to see all young people alone, discussing confidentiality, minimising costs and routinely offering STI screening (using self-collected samples, when appropriate) to all young people can help overcome barriers to STI testing. Useful resources on how to bring up sexual health and related issues can be found here.
  • Providing care to adolescents, particularly younger adolescents, may involve a complete psychosocial HEADSSS Assessment and an assessment of the young person’s capacity for decision making and consent while being aware of child protection issues and mandatory reporting requirements.

Specimen collection guidance

Clinician collected | Self-collection

Clinical indicators for testing

  • Testing for other infections and more frequent testing should be considered based on local STI prevalence, symptoms, clinical findings, diagnosis with an STI, contact with someone with a diagnosed or suspected STI and risk assessment (including specific sexual behaviour and condom use).
  • It is not recommended to routinely test for herpes and genital warts with serology. Consider testing for herpes and genital warts only if there are clinical signs and symptoms.

Cervical cancer screening and STI tests

  • An endocervical swab for nucleic acid amplification test (NAAT) for chlamydia may be collected at the time of cervical cancer screening. Currently in Australia, cervical cancer screening is advised from the age of 25 and has changed from 2-yearly screening to 5-yearly screening.

Special considerations

Privacy

  • Ask the young person about the best way to contact them with test results and reminders. From the age of 15 years, young people can apply for their own Medicare card.

Consent

  • Young people under 18 years may be capable of giving consent to treatment provided they have sufficient understanding of the nature and effect of the treatment. There is specific legislation in New South Wales and South Australia that relates to the medical treatment of children and minors; common law applies in other jurisdictions.

Other factors

  • Be mindful of the language you use. Young people who are trans or gender diverse may not have disclosed this information to you. Ask how your patient identifies and what their preferred pronouns are. Useful resources found here: Gender affirming care (sexual health infolink)
  • It is important when considering which tests are required, to not make assumptions about a young person’s sexuality.

Child protection

If test results are positive, refer to relevant STI management section:

Even if all test results are negative, use the opportunity to:

  • Educate about negotiating safer sex, how to use condoms and how to minimise risk, consent and respectful relationships. When appropriate, address contraception needs
  • Vaccinate for hepatitis A, hepatitis B and human papillomavirus (HPV), if susceptible
  • Offer reminders for regular screening tests e.g. annual chlamydia test.

  • 90% of young people attending the practice are tested according to these guidelines.

Our Supporters

  • ASRHA
  • RACP
  • ASHHNA
  • Sexual and Reproductive Health Australia
  • RACGP
  • MSI Australia
  • AusPATH
  • Australian College of Nurse Practitioners
  • Scarlet Alliance, Australian Sex Workers Association